The Manager, Regulatory Affairs (Clinical Labeling), is responsible for the development, maintenance, and oversight of Investigational Medicinal Product (IMP) labeling (also referred to as "Clinical Labeling", "Special Access Scheme labeling", "Compassionate Use labeling", "Early Access Program labeling", etc.) for Telix's investigational products used in global clinical trials. Key Accountabilities: Leads the creation, revision, review, agreement, and maintenance of Investigational Medicinal Product (IMP) labeling (also referred to as "Clinical Labeling", "Special Access Scheme labeling", "Compassionate Use labeling", "Early Access Program labeling", etc.) and Calibration Labeling for Telix's investigational products.